{"id":"https://openalex.org/W3004616640","doi":"https://doi.org/10.1111/fcp.12544","title":"Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population\u2010based study in France","display_name":"Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population\u2010based study in France","publication_year":2020,"publication_date":"2020-02-07","ids":{"openalex":"https://openalex.org/W3004616640","doi":"https://doi.org/10.1111/fcp.12544","mag":"3004616640","pmid":"https://pubmed.ncbi.nlm.nih.gov/32031701"},"language":"en","primary_location":{"id":"doi:10.1111/fcp.12544","doi":"https://doi.org/10.1111/fcp.12544","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12544","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012997824","display_name":"Martin Gauthier","orcid":"https://orcid.org/0000-0001-5338-2071","observed_orcids":["https://orcid.org/0000-0001-5338-2071"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Martin Gauthier","raw_affiliation_strings":["D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France"],"raw_orcid":"https://orcid.org/0000-0001-5338-2071","affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034371048","display_name":"C\u00e9cile Conte","orcid":"https://orcid.org/0000-0002-7787-5740","observed_orcids":["https://orcid.org/0000-0002-7787-5740"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9cile Conte","raw_affiliation_strings":["Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037926403","display_name":"Aurore Palmaro","orcid":"https://orcid.org/0000-0002-5660-9224","observed_orcids":["https://orcid.org/0000-0002-5660-9224"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4387156050","display_name":"Centre d\u2019Investigation Clinique 1436","ror":"https://ror.org/033z83z59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurore Palmaro","raw_affiliation_strings":["INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015207452","display_name":"Emilie Patras de Campaigno","orcid":"https://orcid.org/0000-0002-1631-4464","observed_orcids":["https://orcid.org/0000-0002-1631-4464"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emilie Patras De Campaigno","raw_affiliation_strings":["Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037867730","display_name":"Sandra De Barros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandra De Barros","raw_affiliation_strings":["Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004066423","display_name":"Fran\u00e7oise Huguet","orcid":"https://orcid.org/0000-0002-9576-8578","observed_orcids":["https://orcid.org/0000-0002-9576-8578","https://orcid.org/0000-0002-5302-5784"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Huguet","raw_affiliation_strings":["D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103453300","display_name":"Guy Laurent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Guy Laurent","raw_affiliation_strings":["D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019H\u00e9matologie Institut Universitaire du Cancer\u2010Oncopole 1 Avenue Ir\u00e8ne Joliot\u2010Curie 31059 Toulouse Cedex France","institution_ids":["https://openalex.org/I4210098740"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050870063","display_name":"Maryse Lapeyre\u2010Mestre","orcid":"https://orcid.org/0000-0002-5494-5873","observed_orcids":["https://orcid.org/0000-0002-5494-5873"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4387156050","display_name":"Centre d\u2019Investigation Clinique 1436","ror":"https://ror.org/033z83z59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maryse Lapeyre\u2010Mestre","raw_affiliation_strings":["INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":"https://orcid.org/0000-0002-5494-5873","affiliations":[{"raw_affiliation_string":"INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059752314","display_name":"Fabien Despas","orcid":"https://orcid.org/0000-0002-3116-9963","observed_orcids":["https://orcid.org/0000-0002-3116-9963"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4387156050","display_name":"Centre d\u2019Investigation Clinique 1436","ror":"https://ror.org/033z83z59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabien Despas","raw_affiliation_strings":["INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC 1436 Toulouse, Centre d'Investigation Clinique de Toulouse, Centre Hospitalier Universitaire de Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3019448017","https://openalex.org/I4387156050"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique CHU de Toulouse 37 all\u00e9es Jules Guesde 31000 Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"Service de Pharmacologie M\u00e9dicale et Clinique Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"UMR1027 Inserm Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5012997824"],"corresponding_institution_ids":["https://openalex.org/I4210098740"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.9907,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.75602612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"34","issue":"5","first_page":"612","last_page":"622"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.46459999680519104,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.46459999680519104,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.260699987411499,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.1216999962925911,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.8930000066757202},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":1.0},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.6620000004768372},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5180000066757202},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.609000027179718},{"id":"https://openalex.org/keywords/gender","display_name":"gender","score":0.3779999911785126},{"id":"https://openalex.org/keywords/cancer-diagnosis","display_name":"cancer diagnosis","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8806683421134949},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6054412126541138},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5788813233375549},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5390597581863403},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.5064841508865356},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5042606592178345},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4696487784385681},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4650261402130127},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.44707244634628296},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34522685408592224},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3323713541030884},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.10558795928955078},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011159","descriptor_name":"Population Surveillance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/fcp.12544","doi":"https://doi.org/10.1111/fcp.12544","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12544","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:32031701","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32031701","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04463195v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04463195","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Fundamental & Clinical Pharmacology, 2020, 34 (5), pp.612-622. ⟨10.1111/fcp.12544⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W636311383","https://openalex.org/W1501644741","https://openalex.org/W1505787114","https://openalex.org/W1580539614","https://openalex.org/W1964280661","https://openalex.org/W1967008538","https://openalex.org/W1968747503","https://openalex.org/W1979612262","https://openalex.org/W1980209815","https://openalex.org/W1982173905","https://openalex.org/W1984698679","https://openalex.org/W1991580027","https://openalex.org/W2001756075","https://openalex.org/W2013450609","https://openalex.org/W2040721909","https://openalex.org/W2074015360","https://openalex.org/W2078379384","https://openalex.org/W2079517811","https://openalex.org/W2082580993","https://openalex.org/W2093470882","https://openalex.org/W2096034121","https://openalex.org/W2127788447","https://openalex.org/W2134883702","https://openalex.org/W2146692373","https://openalex.org/W2149603226","https://openalex.org/W2164168439","https://openalex.org/W2166270808","https://openalex.org/W2199914463","https://openalex.org/W2342470309","https://openalex.org/W2343511371","https://openalex.org/W2415913839","https://openalex.org/W2460065340","https://openalex.org/W2492910862","https://openalex.org/W2511681373","https://openalex.org/W2546450634","https://openalex.org/W2587320685","https://openalex.org/W2592075652","https://openalex.org/W2597213291","https://openalex.org/W2603351605","https://openalex.org/W2620566936","https://openalex.org/W2784184181","https://openalex.org/W2789821152","https://openalex.org/W2794354006","https://openalex.org/W2809912065","https://openalex.org/W2887124585","https://openalex.org/W2900773827","https://openalex.org/W2910862485","https://openalex.org/W3046600577","https://openalex.org/W6640777744","https://openalex.org/W6679227598"],"related_works":["https://openalex.org/W4213456902","https://openalex.org/W2492910862","https://openalex.org/W3203612715","https://openalex.org/W2701836952","https://openalex.org/W4391611390","https://openalex.org/W7014448425","https://openalex.org/W2739805053","https://openalex.org/W4224283037","https://openalex.org/W3102986986","https://openalex.org/W2886008236"],"abstract_inverted_index":{"Psychotropic":[0],"drugs":[1],"(PD)":[2],"are":[3],"often":[4],"used":[5],"close":[6],"to":[7,22,90,102,192,238],"a":[8,16,34,74,132,221,225,236,240],"cancer":[9],"diagnosis":[10,35],"and":[11,30,82,97,139,188],"may":[12],"be":[13,193,235],"considered":[14],"as":[15],"way":[17,237],"of":[18,26,36,117,150,182,198],"coping.":[19],"We":[20,136],"aimed":[21],"determine":[23],"the":[24,54,60,115,160,185],"incidence":[25],"anxiolytics,":[27],"hypnotics,":[28],"antidepressants,":[29],"antipsychotics":[31],"initiation":[32,116,154,171,200,219],"around":[33,224],"chronic":[37],"myelogenous":[38],"leukemia":[39],"(CML).":[40],"Population-based":[41],"cohort:":[42],"Data":[43],"were":[44,84,108,129],"extracted":[45],"from":[46],"Systeme":[47],"National":[48],"des":[49],"donn\u00e9es":[50],"de":[51],"Sant\u00e9":[52],"(SNDS,":[53],"French":[55],"health":[56],"insurance":[57],"database)":[58],"at":[59],"regional":[61],"level":[62],"(Midi-Pyrenees":[63],"area,":[64],"2.9":[65],"million":[66],"inhabitants).":[67],"All":[68],"newly":[69],"diagnosed":[70],"patients":[71,147],"treated":[72],"by":[73],"CML":[75,98,120,140,212,226],"tyrosine":[76],"kinase":[77],"inhibitor":[78],"(TKI)":[79],"between":[80],"10/01/2011":[81],"04/01/2014":[83],"included.":[85],"Pre-CML":[86],"(9":[87],"months":[88,92,100,104],"before":[89,93,101],"3":[91],"first":[94],"TKI":[95],"prescription-F-TKI)":[96],"(3":[99],"9":[103],"after":[105],"F-TKI)":[106],"phases":[107],"defined.":[109],"The":[110,143,180],"main":[111],"evaluation":[112],"criterion":[113],"was":[114,156,167,209],"PD":[118,127,153,163,170,199,205,218],"during":[119,184],"phase.":[121,217],"Determinants":[122],"associated":[123,168,194],"with":[124,169,195,231,242],"this":[125],"incident":[126],"use":[128],"studied":[130],"through":[131],"logistic":[133],"regression":[134],"model.":[135],"compared":[137],"pre-CML":[138,186,216],"healthcare":[141,207,244],"consumption.":[142,245],"cohort":[144],"included":[145],"103":[146],"(mean":[148],"age":[149,166],"60.8":[151],"years).":[152],"rate":[155],"35.9%,":[157],"anxiolytics":[158],"being":[159],"most":[161],"initiated":[162],"(59.5%).":[164],"Advanced":[165],"(adjusted":[172],"OR":[173],"=":[174,178],"1.029,":[175],"95%":[176],"CI":[177],"1.001-1.056).":[179],"number":[181],"consultations":[183],"phase":[187],"female":[189],"gender":[190],"tended":[191],"increased":[196],"risk":[197,229],"in":[201,211,215],"univariate":[202],"analysis.":[203],"For":[204],"initiators,":[206],"consumption":[208],"greater":[210],"but":[213],"not":[214],"is":[220],"frequent":[222],"finding":[223],"diagnosis.":[227],"Its":[228],"increases":[230],"age.":[232],"It":[233],"could":[234],"identify":[239],"subgroup":[241],"higher":[243]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-02-14T00:00:00"}